Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E?

Diabetes - 1 May 2006

Dallinga-Thie Geesje M, van Tol Arie, Hattori Hiroaki, Rensen Patrick C N, Sijbrands Eric J G

Abstract excerpt

Plasma phospholipid transfer protein (PLTP) plays an important role in lipoprotein metabolism. PLTP activity is elevated in patients with diabetes, a condition with strongly elevated risk for coronary heart disease. The aim of this study was to test the hypothesis that statins reduce PLTP activity and to examine the potential role of apolipoprotein E (apoE). PLTP activity and apoE were measured in patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein A-I
Share to Apolipoprotein A-II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Atorvastatin

Share to Heptanoic Acids

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Phospholipid Transfer Proteins

Share to Placebos

Share to Pyrroles

Source

Identifiers

PMID: 16644710
DOI: 10.2337/db05-1685

Genes

PLTP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E?PMID 16644710Read ↗

Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.Semantic proximity Read ↗

Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.Semantic proximity Read ↗

Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variant.Semantic proximity Read ↗

Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.Semantic proximity Read ↗

Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitus.Semantic proximity Read ↗

Serum phospholipid transfer protein activity and genetic variation of the PLTP gene.Semantic proximity Read ↗

PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity.Semantic proximity Read ↗

Cholesteryl ester transfer protein and atherosclerosis.Semantic proximity Read ↗

Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation study.Semantic proximity Read ↗

Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice.Semantic proximity Read ↗

Relationship between the cholesterol ester transfer protein TaqIB polymorphism and the lipid-lowering effect of atorvastatin in patients with coronary atherosclerotic heart disease.Semantic proximity Read ↗

Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.